Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 12 of about 12 for MERCK & CO., INC.�
Company Exchange Symbol Last price Quote change Market cap
Ligand Pharmaceuticals Inc. NASDAQ LGND 54.08 +1.03 (1.94%) 1.06B
Ligand Pharmaceuticals Incorporated (Ligand) is a biotechnology company that operates with a business model focused on developing or acquiring assets.
Merck & Co., Inc. NYSE MRK 59.25 -0.41 (-0.69%) 170.57B
Merck & Co., Inc. (Merck), is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, ...
Enzon Pharmaceuticals Inc NASDAQ ENZN 1.08 +0.02 (1.89%) 46.79M
Enzon Pharmaceuticals, Inc. (Enzon) is a biotechnology company. The Company's drug development programs utilize two platforms: Customized PEGylation Linker ...
Alkermes Plc NASDAQ ALKS 55.90 -0.49 (-0.88%) 8.19B
Alkermes Public Limited Company is an integrated, global biopharmaceutical company. The Company has a portfolio of more than 20 commercial drug products and ...
Xenon Pharmaceuticals Inc NASDAQ XENE 12.52 -0.13 (-1.03%) 177.25M
(Teva) (through its subsidiary, Ivax International GmbH), Genentech, Inc. ( Genentech), and Merck & Co., Inc. (Merck) (through its affiliate, Essex Chemie ...
Nektar Therapeutics NASDAQ NKTR 14.98 +0.31 (2.11%) 1.89B
Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms.
MERCK AND CO INC EPA MRK 47.67 -0.20 (-0.42%)
Amphastar Pharmaceuticals Inc NASDAQ AMPH 10.60 +0.04 (0.38%) 475.08M
Amphastar Pharmaceuticals, Inc. is a specialty and generic pharmaceutical company. The Company focuses primarily on developing, manufacturing, marketing and ...
ENZON PHARMACEUT. DL-,01 FRA EZ1 0.891 +0.069 (8.39%)
ALKERMES PLC DL-,01 FRA 8AK 45.66 +1.54 (3.50%)
NEKTAR THERAPEUTICS FRA ITH 11.69 -0.07 (-0.58%)
MERCK & CO INC CEDEAR (10 REP 1 USD0.50) BCBA MRK 0.000